🇺🇸 FDA

Intelligence · Patent portfolio

Alnylam Netherlands Patents

Full USPTO pharma patent portfolio for Alnylam Netherlands — grant dates, expiration, and drug cross-links.

Patents
379
Expiring ≤24m
4

Quick answer

Alnylam Netherlands has 379 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 4 expire within 24 months — use filters for patent-cliff planning.

Page 7 of 8

  1. US 8334373

    Nuclease resistant double-stranded ribonucleic acid

    Expires Mon Dec 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8324366

    Compositions and methods for delivering RNAI using lipoproteins

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8324368

    GNAQ targeted dsRNA compositions and methods for inhibiting expression

    Expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8318693

    Compositions and methods for inhibiting expression of mutant EGFR gene

    Expires Mon Nov 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8293719

    iRNA agents targeting VEGF

    Expires Mon Oct 18 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8288525

    Compositions and methods for inhibiting expression of CD45 gene

    Expires Mon Oct 11 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8273870

    Compositions and methods for inhibiting expression of a mutant gene

    Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8273869

    Lipid formulated dsRNA targeting the PCSK9 gene

    Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8273868

    Compositions and methods for inhibiting viral replication

    Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8268799

    Compositions and methods for inhibiting expression of the HAMP gene

    Expires Mon Sep 13 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8263572

    RNAi modulation of RSV and therapeutic uses thereof

    Expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8227188

    Enhancement of influenza gene expression

    Expires Mon Jul 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8222222

    Compositions and methods for inhibiting expression of the PCSK9 gene

    Expires Mon Jul 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8202980

    Method and medicament for inhibiting the expression of a given gene

    Expires Mon Jun 14 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8188061

    RNAi modulation of APOB and uses thereof

    Expires Mon May 24 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8183362

    Method and medicament for inhibiting the expression of a given gene

    Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8168776

    Method for making a 21 nucleotide double stranded RNA chemically linked at one end

    Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8168775

    Compositions and methods for inhibiting expression of transthyretin

    Expires Mon Apr 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8163711

    Compositions and methods for inhibiting expression of the HAMP gene

    Expires Mon Apr 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8158601

    Lipid formulation

    Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8158773

    RNAi modulation of RSV and therapeutic uses thereof

    Expires Mon Apr 12 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8148344

    Compositions and methods for mediating RNAi in vivo

    Expires Mon Mar 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8143390

    Compositions and methods for inhibiting expression of anti-apoptotic genes

    Expires Mon Mar 22 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8119608

    Method and medicament for inhibiting the expression of a given gene

    Expires Mon Feb 16 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8114981

    Method and medicament for inhibiting the expression of a given gene

    Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8114984

    RNAi modulation of Aha and therapeutic uses thereof

    Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8114851

    Method and medicament for inhibiting the expression of a given gene

    Expires Mon Feb 09 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8110674

    Therapeutic compositions

    Expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 8106022

    Carbohydrate conjugates as delivery agents for oligonucleotides

    Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 8101742

    Method and medicament for inhibiting the expression of a given gene

    Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 8101584

    Method and medicament for inhibiting the expression of a given gene

    Expires Mon Jan 19 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 8080532

    Compositions and methods for inhibiting expression of Huntingtin gene

    Expires Mon Dec 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 8058257

    Compositions and methods for inhibiting expression of a gene from the JC virus

    Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 8034376

    Lipid containing formulations

    Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 8034793

    RNAi modulation of MLL-AF4 and uses thereof

    Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 8017762

    Modified iRNA agents

    Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 8017763

    Chemically modified oligonucleotides

    Expires Mon Sep 08 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 8013136

    Oligonucleotides comprising a non-phosphate backbone linkage

    Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 8003619

    Method of stimulating an immune response and inhibiting expression of a gene using an oligonucleotide

    Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7994307

    RNAi modulation of the BCR-ABL fusion gene and uses thereof

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7994309

    Compositions and methods for inhibiting expression of a mutant gene

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7985581

    Multiple RNA polymerase III promoter expression constructs

    Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7981869

    RNAi modulation of RSV and therapeutic uses thereof

    Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7956177

    dsRNA compositions and methods for treating HPV infection

    Expires Mon Jun 02 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7947659

    iRNA agents targeting VEGF

    Expires Mon May 19 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7928217

    Nuclease resistant double-stranded ribonucleic acid

    Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7919473

    IRNA agents targeting VEGF

    Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7906484

    Complex for transferring an anionic substance into a cell

    Expires Mon Mar 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Alnylam Netherlands have?

379 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Alnylam Netherlands patents expire?

4 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.